Total Payments
$45,715
2024 Payments
$715.25
Companies
13
Transactions
46
Medicare Patients
585
Medicare Billing
$206,736
Payment Breakdown by Category
Consulting$34,075 (74.5%)
Other$9,540 (20.9%)
Food & Beverage$1,119 (2.4%)
Travel$966.93 (2.1%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,075 | 18 | 74.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,735 | 5 | 19.1% |
| Food and Beverage | $1,119 | 17 | 2.4% |
| Travel and Lodging | $966.93 | 4 | 2.1% |
| Honoraria | $805.00 | 1 | 1.8% |
| Education | $13.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Partner Therapeutics, Inc. | $26,640 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $15,600 | 10 | $0 (2022) |
| Theravance Biopharma Inc. | $1,750 | 1 | $0 (2017) |
| The Medicines Company | $830.08 | 2 | $0 (2017) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.47 | 2 | $0 (2018) |
| Grifols USA, LLC | $125.00 | 1 | $0 (2019) |
| Boston Scientific Corporation | $123.03 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $122.83 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $122.27 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $715.25 | 2 | Partner Therapeutics, Inc. ($715.25) |
| 2023 | $6,009 | 6 | Partner Therapeutics, Inc. ($5,975) |
| 2022 | $12,325 | 15 | Partner Therapeutics, Inc. ($7,707) |
| 2021 | $20,856 | 8 | Partner Therapeutics, Inc. ($12,243) |
| 2020 | $1,138 | 1 | GlaxoSmithKline, LLC. ($1,138) |
| 2019 | $1,670 | 6 | GlaxoSmithKline, LLC. ($1,300) |
| 2018 | $267.58 | 2 | COMSORT, Inc ($150.00) |
| 2017 | $2,735 | 6 | Theravance Biopharma Inc. ($1,750) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2024 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $65.25 | General |
| Category: Hematology/Oncology | ||||||
| 06/21/2024 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/19/2023 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Hematology/Oncology | ||||||
| 10/12/2023 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| Category: Hematology/Oncology | ||||||
| 08/30/2023 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $73.65 | General |
| Category: Hematology/Oncology | ||||||
| 07/21/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/19/2023 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Hematology/Oncology | ||||||
| 01/05/2023 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $9.38 | General |
| Category: Hematology/Oncology | ||||||
| 11/30/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Travel and Lodging | Cash or cash equivalent | $337.20 | General |
| Category: Hematology/Oncology | ||||||
| 11/30/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Travel and Lodging | Cash or cash equivalent | $129.36 | General |
| Category: Hematology/Oncology | ||||||
| 11/30/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Travel and Lodging | Cash or cash equivalent | $101.49 | General |
| Category: Hematology/Oncology | ||||||
| 11/04/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/02/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Travel and Lodging | Cash or cash equivalent | $398.88 | General |
| Category: Hematology/Oncology | ||||||
| 11/01/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $101.12 | General |
| Category: Hematology/Oncology | ||||||
| 10/28/2022 | ALK-Abello, Inc | — | Food and Beverage | In-kind items and services | $67.73 | General |
| 10/10/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $54.00 | General |
| Category: Hematology/Oncology | ||||||
| 09/17/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Hematology/Oncology | ||||||
| 08/02/2022 | Partner Therapeutics, Inc. | LEUKINE (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: Hematology/Oncology | ||||||
| 04/01/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| 04/01/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| 04/01/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 02/22/2022 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $937.50 | General |
| Category: Hematology/Oncology | ||||||
| 02/22/2022 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $95.09 | General |
| Category: Hematology/Oncology | ||||||
| 12/31/2021 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,575.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/22/2021 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $5,118.33 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 130 | 294 | $422,172 | $41,584 |
| 2022 | 7 | 170 | 413 | $538,969 | $58,426 |
| 2021 | 7 | 145 | 294 | $366,190 | $39,350 |
| 2020 | 4 | 140 | 420 | $422,325 | $67,376 |
Total Patients
585
Total Services
1,421
Medicare Billing
$206,736
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 192 | $345,600 | $33,364 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 34 | $29,172 | $2,527 | 8.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 18 | 26 | $20,800 | $2,316 | 11.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 28 | $13,160 | $1,900 | 14.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 14 | $13,440 | $1,477 | 11.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 56 | 210 | $378,000 | $41,205 | 10.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 31 | 85 | $68,000 | $8,479 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 44 | $37,752 | $3,554 | 9.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 25 | $17,000 | $2,108 | 12.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 17 | $16,320 | $1,921 | 11.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 12 | 13 | $20,605 | $935.04 | 4.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 16 | 19 | $1,292 | $223.79 | 17.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 43 | 130 | $234,000 | $25,563 | 10.9% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 24 | 55 | $44,000 | $5,402 | 12.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 38 | $32,604 | $2,849 | 8.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 18 | $17,280 | $2,175 | 12.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 22 | $14,960 | $2,141 | 14.3% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 12 | 14 | $22,190 | $1,018 | 4.6% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 12 | 17 | $1,156 | $202.81 | 17.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 70 | 300 | $360,000 | $57,415 | 15.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 41 | $18,655 | $3,676 | 19.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 14 | 34 | $18,020 | $3,669 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 45 | $25,650 | $2,616 | 10.2% |
About Dr. Tisha Wang, MD
Dr. Tisha Wang, MD is a Critical Care Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164607461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tisha Wang, MD has received a total of $45,715 in payments from pharmaceutical and medical device companies, with $715.25 received in 2024. These payments were reported across 46 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($34,075).
As a Medicare-enrolled provider, Wang has provided services to 585 Medicare beneficiaries, totaling 1,421 services with total Medicare billing of $206,736. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Internal Medicine
- Location Los Angeles, CA
- Active Since 01/04/2008
- Last Updated 07/08/2011
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1164607461
Products in Payments
- LEUKINE (Drug) $13,364
- Leukine (Drug) $13,276
- VIBATIV (Drug) $1,750
- VABOMERE (Drug) $805.00
- ZERBAXA (Drug) $150.00
- Prolastin-C (Biological) $125.00
- ACQUIRE (Device) $123.03
- ELIQUIS (Drug) $122.83
- Non-Covered (Drug) $122.27
- Fetroja (Drug) $34.57
- MINOCIN IV (Drug) $25.08
- STIOLTO (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Los Angeles
Igor Barjaktarevic, M.d., M.sc, M.D., M.SC
Critical Care Medicine — Payments: $353,438
Critical Care Medicine $353,438
Dr. Scott Oh, D.o, D.O
Critical Care Medicine — Payments: $273,819
Critical Care Medicine $273,819
David Boldt, M.d, M.D
Critical Care Medicine — Payments: $132,503
Critical Care Medicine $132,503
Andrew Wachtel, M.d, M.D
Critical Care Medicine — Payments: $45,694
Critical Care Medicine $45,694
Frances Dy, Np, NP
Critical Care Medicine — Payments: $40,496
Critical Care Medicine $40,496
Christopher Newth, Md, MD
Critical Care Medicine — Payments: $29,227
Critical Care Medicine $29,227